Novavax (NVAX) Gross Profit Growth (1y) (2012 - 2026)
Powered by 
Analysis
Novavax (NVAX) Gross Profit Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 11.24% |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 15.59% |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 63.51% |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 126.09% |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 33.01% |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 57.16% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 351.57% |
| 10 | Novavax | 1.67 Bn | 951.85 Mn | 42.45 Mn | -81.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -81.04% |
| Mar 31, 2026 | -83.32% |
| Dec 31, 2025 | 142.12% |
| Sep 30, 2025 | 104.87% |
| Jun 30, 2025 | -39.36% |
| Mar 31, 2025 | 1,783.45% |
| Dec 31, 2024 | -62.13% |
| Sep 30, 2024 | -72.87% |
| Jun 30, 2024 | 0.16% |
| Mar 31, 2024 | -26.07% |
| Dec 31, 2023 | -22.36% |
| Sep 30, 2023 | -70.65% |
| Jun 30, 2023 | 532.93% |
| Mar 31, 2023 | -93.20% |
| Dec 31, 2022 | -20.96% |
| Sep 30, 2022 | 67.74% |
| Jun 30, 2022 | -128.57% |
| Mar 31, 2022 | 54.01% |
| Sep 30, 2015 | -9.77% |
| Jun 30, 2015 | 258.22% |